相关实验视频
Updated: Jul 1, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
平衡行为:糖尿病管理中的快速高血糖正的困境
Ke-Xin Zhang1, Cheng-Xia Kan1, Xiao-Dong Sun2
1Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.
World journal of diabetes
|March 11, 2024
概括
在糖尿病中快速降低血糖可以矛盾地恶化微血管并发症. 医疗保健提供者必须平衡血糖控制,避免为患者的福祉过度纠正.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 糖尿病的全球增长需要有效的血糖控制策略.
- 慢性高血糖症的积极纠正会带来微血管并发症的风险.
- 了解快速降血糖引起的并发症背后的机制至关重要.
研究的目的:
- 在糖尿病管理中重新评估血糖校正的速度和强度.
- 为了强调过于快速降低血糖的潜在不良影响.
- 倡导对糖尿病护理采取个性化和谨慎的方法.
主要方法:
- 这是一个编辑的文章,而不是一个研究研究;因此,没有使用任何特定的方法.
- 内容基于有关糖尿病管理的现有理论和临床观察.
- 提出了对当前血糖控制实践的批判性审查.
主要成果:
- 血糖的快速降低可能会引起炎症,氧化应激和神经血管变化.
- 这些变化可以加速或加剧微血管并发症.
- 需要采取细微的方法,特别是对于长期患有控制不良糖尿病的患者.
结论:
- 医疗保健提供者应谨慎使用积极的血糖控制协议.
- 个性化的糖尿病管理,包括教育和跨学科的护理是必不可少的.
- 平衡短期的血糖目标与长期的健康和并发症预防至关重要.
相关概念视频
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K

